The survey was disseminated among biopharma CEOs and regulatory affairs leaders and focused on recent experiences with the ...

The CDC is instructing scientists to end all research involving monkeys by the end of the year, in a move that will ...

Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of ...

The Fierce team will be out of office next Friday for the Thanksgiving holiday. The next edition of Chutes & Ladders will ...

GE HealthCare plans to pay $2.3 billion in cash to acquire imaging software developer Intelerad, toward the goal of building ...

The FDA says it is hiring more than 1,000 new employees and rolling out a pilot communication program in efforts to speed up ...

While the board considers which path to take, it is implementing various “cost-containment and cash conservation measures,” ...

GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal ...

Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ...

Precise Bio has reported the first successful human implantation of its 3D-printed cornea implant, constructed of functional ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics ...

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...